Other Name(s): Toll, Toll-like Receptor 4, Toll
Assay:Antagonistic potency at human TLR4 expressed in HEK293 cells
Type:IC50
SMILES:CCCCCCCCCCCCCC(=O)N[C@H](COCC[C@@H](CCCCCCC)OC(=O)CCCCCCCCCCC)COP(=O)(O)OCCNC(=O)C(Cc1ccc(O)cc1)C(=O)O
Value:=350nM
Source:Homo sapiens
Assay:Antagonistic potency at human TLR4 expressed in HEK293 cells
Type:IC50
SMILES:CCCCCCCCCCCCCC(=O)N[C@@H](COCC[C@@H](CCCCCCC)OC(=O)CCCCCCCCCCC)COP(=O)(O)OCCNC(=O)C(Cc1ccc(O)cc1)C(=O)O
Value:=250nM
Source:Homo sapiens
Assay:Antagonistic potency at human TLR4 expressed in HEK293 cells
Type:IC50
SMILES:CCCCCCCCCCCCCC(=O)N[C@@H](COCC[C@H](CCCCCCC)OC(=O)CCCCCCCCCCC)COP(=O)(O)OCCNC(=O)C(Cc1ccc(O)cc1)C(=O)O
Value:=80nM
Source:Homo sapiens
Assay:Antagonistic potency at human TLR4 expressed in HEK293 cells
Type:IC50
SMILES:CCCCCCCCCCCCCC(=O)N[C@H](COCC[C@H](CCCCCCC)OC(=O)CCCCCCCCCCC)COP(=O)(O)OCCNC(=O)C(Cc1ccc(O)cc1)C(=O)O
Value:=160nM
Source:Homo sapiens
Assay:Inhibition of induction of NF-kappaB by LPS in HEK293 cells co-transfected with TLR4, CD14 and MD2
Type:IC50
SMILES:CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O
Value:=1230nM
Source:Homo sapiens
Assay:Inhibition of induction of NF-kappaB by LPS in HEK293 cells co-transfected with TLR4, CD14 and MD2
Type:IC50
SMILES:CCCCCCCCCCCCCCOc1c(/C=N/N=C(N)N)ccc(/C=N/N=C(N)N)c1OCCCCCCCCCCCCCC.Cl.Cl
Value:=190000nM
Source:Homo sapiens
Assay:Inhibition of induction of NF-kappaB by LPS in HEK293 cells co-transfected with TLR4, CD14 and MD2
Type:IC50
SMILES:CCCCCCCCOc1c(/C=N/N=C(N)N)ccc(/C=N/N=C(N)N)c1OCCCCCCCC.Cl.Cl
Value:=4500nM
Source:Homo sapiens
Assay:Inhibition of induction of NF-kappaB by LPS in HEK293 cells co-transfected with TLR4, CD14 and MD2
Type:IC50
SMILES:CCCCCCOc1c(/C=N/N=C(N)N)ccc(/C=N/NC(=N)N)c1OCCCCCC.Cl.Cl
Value:=6110nM
Source:Homo sapiens
Assay:Inhibition of induction of NF-kappaB by LPS in HEK293 cells co-transfected with TLR4, CD14 and MD2
Type:IC50
SMILES:CCCCCOc1c(/C=N/N=C(N)N)ccc(/C=N/N=C(N)N)c1OCCCCC.Cl.Cl
Value:=10500nM
Source:Homo sapiens
Assay:Inhibition of induction of NF-kappaB by LPS in HEK293 cells co-transfected with TLR4, CD14 and MD2
Type:IC50
SMILES:CCCCOc1c(/C=N/N=C(N)N)ccc(/C=N/NC(=N)N)c1OCCCC.Cl.Cl
Value:=9400nM
Source:Homo sapiens
Assay:Inhibition of induction of NF-kappaB by LPS in HEK293 cells co-transfected with TLR4, CD14 and MD2
Type:IC50
SMILES:C=CCOc1c(/C=N/NC(=N)N)ccc(/C=N/NC(=N)N)c1OCC=C.Cl.Cl
Value:=61400nM
Source:Homo sapiens
Assay:Inhibition of induction of NF-kappaB by LPS in HEK293 cells co-transfected with TLR4, CD14 and MD2
Type:IC50
SMILES:CCCOc1c(/C=N/N=C(N)N)ccc(/C=N/N=C(N)N)c1OCCC.Cl.Cl
Value:=27600nM
Source:Homo sapiens
Assay:Inhibition of induction of NF-kappaB by LPS in HEK293 cells co-transfected with TLR4, CD14 and MD2
Type:IC50
SMILES:CCOc1c(/C=N/N=C(N)N)ccc(/C=N/N=C(N)N)c1OCC.Cl.Cl
Value:=35600nM
Source:Homo sapiens
Assay:Inhibition of induction of NF-kappaB by LPS in HEK293 cells co-transfected with TLR4, CD14 and MD2
Type:IC50
SMILES:COc1c(/C=N/N=C(N)N)ccc(/C=N/NC(=N)N)c1OC.Cl.Cl
Value:=175000nM
Source:Homo sapiens
Assay:Inhibition of induction of NF-kappaB by LPS in HEK293 cells co-transfected with TLR4, CD14 and MD2
Type:IC50
SMILES:Cl.Cl.N=C(N)N/N=C/c1ccc(/C=N/NC(=N)N)c(O)c1O
Value:=59100nM
Source:Homo sapiens
Assay:Inhibition of induction of NF-kappaB by LPS in HEK293 cells co-transfected with TLR4, CD14 and MD2
Type:IC50
SMILES:Cl.Cl.N=C(N)N/N=C/c1ccc(/C=N/NC(=N)N)cc1
Value:=164000nM
Source:Homo sapiens
Assay:Antagonist activity at TLR4 in human PBMC assessed as inhibition of LPS-stimulated TNFalpha production pre-incubated for 30 mins before LPS challenge measured after 18 hrs by ELISA
Type:IC50
SMILES:CCCCCCCCCCC[C@H](CC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](OP(=O)(O)O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCC)[C@H]1NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCC)C(=O)O)OC(=O)CCCCC
Value:=2.4nM
Source:Homo sapiens
Assay:Antagonist activity at TLR4 in human PBMC assessed as inhibition of LPS-stimulated TNFalpha production pre-incubated for 30 mins before LPS challenge measured after 18 hrs by ELISA
Type:IC50
SMILES:CCCCCCCCCCC[C@H](CC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](OP(=O)(O)O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OCCCCCC)[C@H]1NC(=O)C[C@@H](CCCCCCCCCCC)OCCCCCC)C(=O)O)OCCCCCC
Value:=5.3nM
Source:Homo sapiens
Assay:Agonist activity at TLR4 in human PBMC assessed as induction of TNFalpha production after 18 hrs by sandwich ELISA
Type:ED50
SMILES:CCCCCCCCCCC[C@H](CC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](OP(=O)(O)O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCC)[C@H]1NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCC)C(=O)O)OC(=O)CCCCCCCCC
Value:=0.39nM
Source:Homo sapiens
Assay:Agonist activity at TLR4 in human PBMC assessed as induction of TNFalpha production after 18 hrs by sandwich ELISA
Type:ED50
SMILES:CCCCCCCCCCC[C@H](CC(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](OP(=O)(O)O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OCCCCCCCCCC)[C@H]1NC(=O)C[C@@H](CCCCCCCCCCC)OCCCCCCCCCC)C(=O)O)OCCCCCCCCCC
Value:=0.17nM
Source:Homo sapiens

Note: If you'd like to learn how our AI-powered BDE-Chem can help design therapeutic molecules against the TLR4 target, that break through the existing patents, at a cost 90% lower than traditional approaches, please feel free to contact us at BD@silexon.ai

Molecules for More Common Targets

ABCB1 | ABCG2 | ACE2 | AHR | AKT1 | ALK | AR | ATM | BAX | BCL2 | BCL2L1 | BRAF | BRCA1 | CASP3 | CASP9 | CCL5 | CCND1 | CD274 | CD4 | CDKN1A | CXCL8 | CXCR4 | DNMT1 | EGF | EGFR | EP300 | ERBB2 | ESR1 | EZH2 | FN1 | FOXO3 | HDAC9 | HGF | HMGB1 | HSP90AA1 | HSPA5 | IDO1 | IGF1 | IGF1R | IL17A | IL6 | INS | JUN | KRAS | MAPK1 | MAPK14 | MAPK3 | MAPK8 | MAPT | MCL1 | MMP9 | MTOR | MYC | NFE2L2 | NLRP3 | NOTCH1 | PARP1 | PCNA | PDCD1 | PLK1 | PRKAA1 | PRKAA2 | PTEN | PTGS2 | PTK2 | RELA | SIRT1 | SRC | STAT1 | STAT3 | STAT5A | TERT | TLR4 | TNF | TP53 | TXN | VEGFA | YAP1